Asim Rizvi, MD | |
301 University Blvd, Galveston, TX 77555-2399 | |
(215) 964-7311 | |
Not Available |
Full Name | Asim Rizvi |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 23 Years |
Location | 301 University Blvd, Galveston, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265099014 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
University Of Texas Medical Branch Galveston | Galveston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Texas Medical Branch Faculty Group Practice | 3375456734 | 875 |
News Archive
I still remember exactly where I was sitting decades ago, during the short film shown in class: For a few painful minutes, we watched a woman talking mechanically, raspily through a hole in her throat, pausing occasionally to gasp for air.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the Israeli Ministry of Health has approved the use of its drug CF102 for a patient with hepatocellular carcinoma, the most common form of liver cancer, under the country's Compassionate Use Program.
How would you rate your own physical fitness? Is it good, satisfactory or maybe even poor? Surprisingly, your answer may reveal your future risk of getting dementia.
New Zealand biotech Symansis has purchased Australian company Apollo Cytokine Research for A$500,000 (NZ$627,000) to build on its unique cell signaling science and fast track expansion into new international markets.
Cancer cells have evolved multiple escape strategies to circumvent the body's immune defenses such as the attack by Natural Killer (NK) cells which normally swiftly kill abnormal cells by releasing cytotoxic products.
› Verified 1 days ago
Entity Name | Utmb Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
I still remember exactly where I was sitting decades ago, during the short film shown in class: For a few painful minutes, we watched a woman talking mechanically, raspily through a hole in her throat, pausing occasionally to gasp for air.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the Israeli Ministry of Health has approved the use of its drug CF102 for a patient with hepatocellular carcinoma, the most common form of liver cancer, under the country's Compassionate Use Program.
How would you rate your own physical fitness? Is it good, satisfactory or maybe even poor? Surprisingly, your answer may reveal your future risk of getting dementia.
New Zealand biotech Symansis has purchased Australian company Apollo Cytokine Research for A$500,000 (NZ$627,000) to build on its unique cell signaling science and fast track expansion into new international markets.
Cancer cells have evolved multiple escape strategies to circumvent the body's immune defenses such as the attack by Natural Killer (NK) cells which normally swiftly kill abnormal cells by releasing cytotoxic products.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Asim Rizvi, MD 3102 W Bay Area Blvd Apt 1805, Friendswood, TX 77546-5089 Ph: (215) 964-7311 | Asim Rizvi, MD 301 University Blvd, Galveston, TX 77555-2399 Ph: (215) 964-7311 |
News Archive
I still remember exactly where I was sitting decades ago, during the short film shown in class: For a few painful minutes, we watched a woman talking mechanically, raspily through a hole in her throat, pausing occasionally to gasp for air.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the Israeli Ministry of Health has approved the use of its drug CF102 for a patient with hepatocellular carcinoma, the most common form of liver cancer, under the country's Compassionate Use Program.
How would you rate your own physical fitness? Is it good, satisfactory or maybe even poor? Surprisingly, your answer may reveal your future risk of getting dementia.
New Zealand biotech Symansis has purchased Australian company Apollo Cytokine Research for A$500,000 (NZ$627,000) to build on its unique cell signaling science and fast track expansion into new international markets.
Cancer cells have evolved multiple escape strategies to circumvent the body's immune defenses such as the attack by Natural Killer (NK) cells which normally swiftly kill abnormal cells by releasing cytotoxic products.
› Verified 1 days ago
Dr. James Harold Pavela, MD Nephrology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-7063 Fax: 409-747-8579 | |
Diaa Hamouda, MBBCH Nephrology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Jsa 9.128, Galveston, TX 77555 Phone: 409-772-8031 Fax: 409-772-6940 | |
Syed Mustajab Hasan, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1005 Harborside Drive, Galveston, TX 77555 Phone: 409-762-2328 Fax: 832-632-7866 | |
Arielle Degueure, MD Nephrology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883 Fax: 409-747-8579 | |
Dr. Shawn Pua Eiko Nishi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-643-4587 | |
Suyuan Tan, Nephrology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883 | |
Shahzad Jokhio, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-722-2222 |